Acceleron Pharma revenue was $73.99 m in FY, 2019 which is a 428.9% year over year increase from the previous period.
Acceleron Pharma revenue breakdown by business segment: 96.0% from Cost-Sharing and 4.0% from Other
|FY, 2019||FY, 2018||FY, 2017|
|Cost-Sharing||13.99 m||13.99 m||12.94 m|
|License and Milestone||60 m||541 k|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.